TRexit is going one step further

Roberto Miano^#^{1

2}, Guglielmo Manenti³, Luca Orecchia^#⁴

Affiliations

¹ Urology Unit, AOU Policlinico Tor Vergata, Rome, Italy. mianor@virgilio.it.
² Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy. mianor@virgilio.it.
³ Department of Diagnostic and Interventional Radiology, Molecular Imaging and Radiotherapy, AOU Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
⁴ Urology Unit, AOU Policlinico Tor Vergata, Rome, Italy.

^# Contributed equally.

Editorial

Roberto Miano et al. Prostate Cancer Prostatic Dis. 2024 Sep.

. 2024 Sep;27(3):361-362.

doi: 10.1038/s41391-024-00819-x. Epub 2024 Mar 13.

Roberto Miano^#^{1

2}, Guglielmo Manenti³, Luca Orecchia^#⁴

¹ Urology Unit, AOU Policlinico Tor Vergata, Rome, Italy. mianor@virgilio.it.
² Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy. mianor@virgilio.it.
³ Department of Diagnostic and Interventional Radiology, Molecular Imaging and Radiotherapy, AOU Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.
⁴ Urology Unit, AOU Policlinico Tor Vergata, Rome, Italy.

^# Contributed equally.

No abstract available

References

1. Grummet J, Gorin MA, Popert R, O’Brien T, Lamb AD, Hadaschik B, et al. “TREXIT 2020”: why the time to abandon transrectal prostate biopsy starts now. Prostate Cancer Prostatic Dis. 2020;23:62–5. - DOI - PubMed - PMC
1. Newman TH, Stroman L, Hadjipavlou M, Haque A, Rusere J, Chan K, et al. EXIT from TRansrectal prostate biopsies (TREXIT): sepsis rates of transrectal biopsy with rectal swab culture guided antimicrobials versus freehand transperineal biopsy. Prostate Cancer Prostatic Dis. 2022;25:283–7. - DOI - PubMed
1. Mian BM, Feustel PJ, Aziz A, Kaufman RP, Bernstein A, Avulova S, et al. Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. J Urol. 2024;211:205–13. - DOI - PubMed
1. Mian BM, Kaufman RP, Fisher HAG. Rationale and protocol for randomized study of transrectal and transperineal prostate biopsy efficacy and complications (ProBE-PC study). Prostate Cancer Prostatic Dis. 2021;24:688–96. - DOI - PubMed
1. Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol. 2024.